Privacy Policy

What Information Do We Collect?

We collect information you submit when you register on our site or subscribe to our updates. When registering on our site, you may be asked to enter your name, email address, and country. You may, however, visit our site anonymously.

What Do We Use Your Information For?

To send periodic emails - The email address you provide for order processing may be used to send you information and updates pertaining to your order, in addition to occasional company news, updates, related product or service information, etc. If at any time you would like to unsubscribe from receiving future emails, you can log in  to your account to unsubscribe. To process transactions - Your information, whether public or private, will not be sold, exchanged, transferred, or given to any other company for any reason whatsoever, without your consent, other than for the express purpose of delivering the purchased product or service requested.

Do We Disclose Any Information to Outside Parties?

We do not sell, trade, or otherwise transfer to outside parties your personally identifiable information. This does not include trusted third parties who assist us in operating our website, conducting our business, or servicing you, so long as those parties agree to keep this information confidential. We may also release your information when we believe release is appropriate to comply with the law, enforce our site policies, or protect our or others’ rights, property, or safety. However, non-personally identifiable visitor information may be provided to other parties for marketing, advertising, or other uses.

Third-Party Links

Occasionally, at our discretion, we may include or offer third-party products or services on our website. These third-party sites have separate and independent privacy policies. We therefore have no responsibility or liability for the content and activities of these linked sites.

Online Privacy Policy Only

This online Privacy Policy applies only to information collected through our website and not to any information collected offline.

Your Consent

By using our site, you consent to our website Privacy Policy.

Contact Us

Should you have any questions or comments related to this Privacy Policy, please click contact us.

Sorry, your login failed because you disagree with our privacy policy and we are unable to collect your data.

NOT REAL NEWS: A look at what didn\'t happen this week
  1. Home
  2. >
  3. Forums
  4. >
  5. Home Gadgets
  6. >
  7. NOT REAL NEWS: A look at what didn\'t happen this week
New Topic

NOT REAL NEWS: A look at what didn\'t happen this week

Views: 3 Replies: 0

All reply (0)

Aug 06, 2021 at 02:15
Topics: 70 Posts: 0
CLAIM: Because 14 people in Pfizer’s placebo group died and 15 people in the vaccinated group also died, Pfizer’s own data shows its COVID-19 vaccine does not reduce the risk of dying from the disease.

THE FACTS: Those figures are irrelevant to the vaccine’s efficacy, as they are simply a tally of all deaths that occurred among participants in both the placebo and vaccine groups in Pfizer’s ongoing study. Pfizer’s data shows that the vaccine is highly effective at preventing serious illness. Data from countries that have used the vaccine widely show it is also effective at preventing death from COVID-19. On July 28, Pfizer released updated data from its vaccine study showing that as of mid-March, the shots were 97% effective in preventing severe disease from COVID-19 up to 6 months later. The data also showed the shots’ efficacy against COVID-19 symptoms dropped slightly with time: it peaked at 96% efficacy 2 months after the shots were administered and fell to 84% after 6 months. The Food and Drug Administration granted emergency use authorization for the company’s vaccine in December 2020 after reviewing earlier data from Pfizer’s ongoing study, which includes 44,000 participants. The newly released data includes 6 months of follow-up data that is required to get full FDA approval. It is expected that in any long-term study, some participants will die for unrelated reasons. Clinical trials monitor deaths to watch for any potential red flags. Pfizer’s study states that 14 people in the placebo group and 15 people in the vaccinated group died before January 2021. The vast majority of the deaths were unrelated to COVID-19. Only two people in the placebo group died of COVID-19 and one person in the vaccinated group died of COVID-19 pneumonia, according to additional Pfizer data obtained by The Associated Press. The rest of the deaths were due to other factors, including heart disease and heart attacks. The report states that none of the deaths were related to the vaccine. A widely shared tweet misrepresented the significance of the death numbers to falsely suggest those deaths meant the Pfizer’s vaccine doesn’t reduce a person’s chance of dying from the virus: “The pivotal clinical trial for the @pfizer #Covid vaccine shows it does nothing to reduce the overall risk of death. ZERO. 15 patients who received the vaccine died; 14 who received placebo died,” the tweet reads. But those death figures, which include everyone in the study who died before January 2021, are irrelevant to the question of how efficient the vaccine is at preventing COVID-19 deaths. The claim made in the Twitter post “is not supportable by these data,” said Dr. David J. Cennimo, an infectious disease expert at the Rutgers New Jersey Medical School. The fact that both the vaccinated group and the control group had a similar number of deaths from causes other than COVID-19 is to be expected, Cennimo said. “To exaggerate the example for learning, the Pfizer vaccine doesn’t protect you from lightning strikes so equal numbers of people in the vaccine and the placebo control group should get hit by lightning,” Cennimo said. In fact, the tweet’s assertion that the Pfizer study aimed to measure efficacy against death is also wrong, Cennimo said. Rather, the study was designed to look at how effective the vaccine is at protecting against symptomatic illness. Since death from COVID-19 is a much rarer event than a COVID-19 infection, Cennimo said a much larger study sample is needed to answer that question. Real-world data from hundreds of millions of Pfizer vaccine doses administered in the United States, the United Kingdom and Israel show that the vaccine is exceedingly effective at protecting against death. A spokesperson for Pfizer told the AP the company could not comment on specific cases, but said, “No deaths were considered by the investigators to be related to the vaccine or placebo.”

Aug 06, 2021 at 02:15
New Topic
Reply to XXXX, click to continue
The content can not be empty.
Create a new topic,click to continue.
Home Gadgets Reply

Post New Topic to the Forum: Smart Camera


The title can not be empty.


The content can not be empty.